Effects of Sodium Intake on Albumin Excretion in Patients with Diabetic Nephropathy Treated with Long-Acting Calcium Antagonists

Annals of Internal Medicine

Volumn 125, Issue 3, 1996, Pages 201-204

  Bakris, George L ^a   Smith, Amy ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DILTIAZEM; NIFEDIPINE;

AGED; ALBUMINURIA; ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DIABETIC NEPHROPATHY; FEMALE; HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDY; SODIUM INTAKE; URINE;

AGED; ALBUMINURIA; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CLONIDINE; CROSS-OVER STUDIES; DIABETIC NEPHROPATHIES; DILTIAZEM; FEMALE; HUMANS; MALE; MIDDLE AGED; NIFEDIPINE; PROSPECTIVE STUDIES; SODIUM, DIETARY;

EID: 0030211287     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-125-3-199608010-00007     Document Type: Article

References (17)

1. Hebert LA, Bain RP, Verme D, Cattran D, Whittier FC, Tolchin N, et al. Remission of nephrotic range proteinuria in type I diabetes. Collaborative Study Group. Kidney Int. 1994;46:1688-93.
2. Bakris GL, Copley B, Vicknair N, Leurgans S. Long term follow-up of patients with type II diabetes randomized to ACE inhibitors, calcium antagonists or both [Abstract]. J Am Soc Nephrol. 1996;6:440.
3. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and proteinuria in normotensive type II diabetic patients. Ann Intern Med. 1993;118:577-81.
4. Bakris GL. Blood pressure control and progression of diabetic nephropathy: are all antihypertensive drugs created equal? Kidney. A Current Survey of the World Literature. 1994;3:61-2.
5. Bakris G. Hypertension in diabetic patients. An overview of intervention studies to preserve renal function. Am J Hypertens. 1993;6:140S-7S.
6. Maki DD, Ma JZ, Louis TA, Kasiske BL. Long-term effects of antihypertensive agents on proteinuria and renal function. Arch Intern Med. 1995;155: 1073-80.
7. Gaber L, Walton C, Brown S, Bakris G. Effect of antihypertensive treatments on morphologic progression of diabetic nephropathy in uninephrectomized dogs. Kidney Int. 1994;45:161-9.
8. Anderson S, Rennke HG, Brenner BM. Nifedipine versus fosinopril in uninephrectomized diabetic rats. Kidney Int. 1992;41:891-7
9. Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int. 1989;36:272-9.
10. Bank N, Lahorra G, Aynedjian HS, Wilkes BM. Sodium restriction corrects hyperfiltration of diabetes. Am J Physiol. 1988;254(5 Pt 2):F668-76.
11. Bakris GL, Bamhill BW, Sadler R. Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection. Kidney Int. 1992;41:912-9.
12. Hartmann A, Lund K, Holdaas H, Fauchald P, Reisaeter A, Berg KJ. Contrasting short-term effects of nifedipine on glomerular and tubular functions in glomerulonephritic patients. J Am Soc Nephrol. 1994;5:1385-90.
13. Gall MA, Rossing P, Kofoed-Enevoldsen A, Nielson FS, Parving HH. Glomerular size- and charge selectivity in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia. 1994;37:195-201.
14. Jyothirmayi GN, Reddi AS. Effect of diltiazem on glomerular heparin sulfate albuminuria in diabetic rats. Hypertension. 1993;21(6 Pt 1):795-802.
15. Bohler J, Becker A, Reetze-Bonorden P, Woitas R, Keller E, Schollmeyer P. Effects of antihypertensive drugs on glomerular hyperfilteration and renal haemodynamics. Comparison of captopril with nifedipine, metoprolol and celiprolol. Eur J Clin Pharmacol. 1993;44(Suppl 1):S57-61.
16. Abbott KC, Sanders LR, Bakris GL. Microalbuminuria in non-insulin-dependent diabetes mellitus. Implications for renal survival. Arch Intern Med. 1994; 154:146-53.
17. Bakris GL. Microalbuminuria: Prognostic implications. Contemporary Issues In Nephrology and Hypertension. 1996,5:219-23.